1. Home
  2. XOMA

as 03-31-2025 2:23pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Founded: 1981 Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: 250.1M IPO Year: N/A
Target Price: $72.00 AVG Volume (30 days): 32.2K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.65 EPS Growth: N/A
52 Week Low/High: $19.92 - $35.00 Next Earning Date: 03-17-2025
Revenue: $28,487,000 Revenue Growth: 498.72%
Revenue Growth (this year): 29.6% Revenue Growth (next year): 34.18%

XOMA Daily Stock ML Predictions

Share on Social Networks: